Artia Global Partners LP Quant / Systematic

CIK: 0001937964 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $279,810 (100.0% shares, 0.0% debt)

Holdings (37)

SLNO SOLENO THERAPEUTICS INC 7.9%
Value ($000) $22,224 Shares 494,424 Est. Cost $48.81 Unrealized +6.1%
MERUS N V 7.0%
Value ($000) $19,504 Shares 463,840 Est. Cost $42.88 Unrealized
INTRA-CELLULAR THERAPIES INC 6.6%
Value ($000) $18,351 Shares 219,719 Est. Cost $66.31 Unrealized
ACLX ARCELLX INC 6.3%
Value ($000) $17,622 Shares 229,785 Est. Cost $86.39 Unrealized 0.0%
NVO NOVO-NORDISK A S 6.1%
Value ($000) $17,204 Shares 200,000 Est. Cost $113.72 Unrealized
NVO NOVO-NORDISK A S 6.1%
Value ($000) $17,204 Shares 200,000 Est. Cost $113.72 Unrealized
NUVL NUVALENT INC 5.7%
Value ($000) $15,973 Shares 204,045 Est. Cost $92.60 Unrealized +0.9%
PCVX VAXCYTE INC 4.7%
Value ($000) $13,282 Shares 162,255 Est. Cost $79.28 Unrealized +25.2%
ALNY ALNYLAM PHARMACEUTICALS INC 4.7%
Value ($000) $13,271 Shares 56,400 Est. Cost $197.76 Unrealized +33.0%
AZN ASTRAZENECA PLC 4.5%
Value ($000) $12,498 Shares 190,752 Est. Cost $69.76 Unrealized
RVMD REVOLUTION MEDICINES INC 4.4%
Value ($000) $12,430 Shares 284,190 Est. Cost $48.13 Unrealized +4.9%
VERONA PHARMA PLC 4.2%
Value ($000) $11,857 Shares 255,318 Est. Cost $31.60 Unrealized
INSM INSMED INC 4.1%
Value ($000) $11,595 Shares 167,939 Est. Cost $57.73 Unrealized +24.8%
PTGX PROTAGONIST THERAPEUTICS INC 4.1%
Value ($000) $11,343 Shares 293,851 Est. Cost $35.82 Unrealized +21.7%
XBI SPDR SER TR 3.2%
Value ($000) $9,006 Shares 100,000 Est. Cost Unrealized
JANX JANUX THERAPEUTICS INC 3.1%
Value ($000) $8,726 Shares 162,976 Est. Cost $52.89 Unrealized 0.0%
ARGX ARGENX SE 2.5%
Value ($000) $6,956 Shares 11,311 Est. Cost $387.47 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 2.2%
Value ($000) $6,143 Shares 45,000 Est. Cost $117.13 Unrealized +5.6%
NVO NOVO-NORDISK A S 1.5%
Value ($000) $4,301 Shares 50,000 Est. Cost $113.72 Unrealized
VKTX VIKING THERAPEUTICS INC 1.3%
Value ($000) $3,633 Shares 90,279 Est. Cost $28.32 Unrealized +101.3%
RYTM RHYTHM PHARMACEUTICALS INC 1.0%
Value ($000) $2,799 Shares 50,000 Est. Cost $55.24 Unrealized 0.0%
CRNX CRINETICS PHARMACEUTICALS IN 0.8%
Value ($000) $2,340 Shares 45,765 Est. Cost $39.13 Unrealized +43.0%
ELVN ENLIVEN THERAPEUTICS INC 0.8%
Value ($000) $2,315 Shares 102,900 Est. Cost $25.92 Unrealized 0.0%
SPRINGWORKS THERAPEUTICS INC 0.7%
Value ($000) $1,948 Shares 53,930 Est. Cost $49.22 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 0.7%
Value ($000) $1,917 Shares 100,000 Est. Cost $21.74 Unrealized 0.0%
TGTX TG THERAPEUTICS INC 0.6%
Value ($000) $1,641 Shares 54,515 Est. Cost $28.70 Unrealized 0.0%
EYPT EYEPOINT PHARMACEUTICALS INC 0.6%
Value ($000) $1,614 Shares 216,700 Est. Cost $10.79 Unrealized -13.7%
XENE XENON PHARMACEUTICALS INC 0.6%
Value ($000) $1,568 Shares 40,000 Est. Cost $46.00 Unrealized -10.1%
MREO MEREO BIOPHARMA GROUP PLC 0.5%
Value ($000) $1,475 Shares 421,359 Est. Cost $3.30 Unrealized
NAMS NEWAMSTERDAM PHARMA COMPANY 0.5%
Value ($000) $1,395 Shares 54,285 Est. Cost $20.30 Unrealized +4.6%
CNTA CENTESSA PHARMACEUTICALS PLC 0.5%
Value ($000) $1,346 Shares 80,380 Est. Cost $15.99 Unrealized
EWTX EDGEWISE THERAPEUTICS INC 0.5%
Value ($000) $1,335 Shares 50,000 Est. Cost Unrealized
CRL CHARLES RIV LABS INTL INC 0.4%
Value ($000) $1,164 Shares 6,305 Est. Cost $226.63 Unrealized -15.0%
TARS TARSUS PHARMACEUTICALS INC 0.4%
Value ($000) $1,152 Shares 20,811 Est. Cost $45.42 Unrealized 0.0%
ASND ASCENDIS PHARMA A/S 0.4%
Value ($000) $1,024 Shares 7,440 Est. Cost $151.17 Unrealized
ANNX ANNEXON INC 0.3%
Value ($000) $884 Shares 172,226 Est. Cost $5.30 Unrealized +16.2%
TECX TECTONIC THERAPEUTIC INC 0.3%
Value ($000) $769 Shares 16,650 Est. Cost $42.29 Unrealized 0.0%